International Journal of Diabetes Mellitus
Volume 2, Issue 3 , Pages 141-143 , December 2010

Free radical activity in hypertensive type 2 diabetic patients

  • Suvarna Prasad

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: House No. E-54, GH-94, SEC-20, Panchkula, Haryana 134112, India. Tel.: +91 9872174466, +91 9257206509.
    • ,
  • Ajay Kumar Sinha

Received 24 July 2010 ,Accepted 4 October 2010.

References 

  1. Sowers James R, Murray E, Edward DF. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053–1059
  2. Betteridge DJ. What is oxidative stress?. Metabolism. 2000;49:3–8
  3. Tirzitis G, Bartosz G. Determination of antiradical and antioxidant activity: basic principles and new insights. Acta Biochim Pol. 2010;57:139–142
  4. Sies H. Strategies of antioxidant defence. Eur J Biochem. 2005;215:213–219
  5. Ohkawa H, Ohishi N, Yogi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal Biochem. 1979;95:351–358
  6. Kakkar P, Awasthi S, Vishwanathan PN. Oxidative changes in brain of aniline exposed rats. Arch Environ Contam Toxicol. 1992;23:307–309
  7. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannebaum SR. Analysis of nitrate, nitrite, and [N 15] nitrate in biological fluids. Anal Biochem. 1982;126:131–138
  8. Taboshashi K, Saito Y. The role of superoxide anion in relationship between the cardiovascular diseases and the metabolic disorders associated with obesity. Nippon Rinsho. 2000;58:1592–1597
  9. Szaleczky E, Prechl J, Feher J, Somogyi A. Alterations in enzymatic defence in diabetes mellitus – a rational approach. Postgrad Med J. 1999;75:13–17
  10. Ceriello A. New Insights on oxidative stress and diabetic complications may lead to a causal antioxidant therapy. Diabetes Care. 2003;26:1589–1596
  11. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:1159
  12. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes. 2000;49:2170–2177
  13. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycaemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes. 2003;52:846–851
  14. Bruce CR, Carey AL, Hawley JA, Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA is reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Diabetes. 2003;52:2338–2345
  15. Tsutsui Hiroyuki, Kinugawa Shintaro, Matsushima Shouji. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res. 2009;81:449–456

PII: S1877-5934(10)00075-5

doi: 10.1016/j.ijdm.2010.10.002

International Journal of Diabetes Mellitus
Volume 2, Issue 3 , Pages 141-143 , December 2010

Article Tools